Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Wassim, Wazzan"'
Autor:
Nizar Hakam, Nassib Abou Heidar, Jose El-Asmar, Mark Khauli, Jad Degheili, Mouhamad Al-Moussawy, Rami Nasr, Albert El-Hajj, Wassim Wazzan, Muhammad Bulbul, Raja B Khauli
Publikováno v:
Urology Annals, Vol 15, Iss 2, Pp 226-231 (2023)
Objectives: Over the past 20 years, the utility of partial nephrectomy (PN), compared to radical nephrectomy (RN), for the management of localized renal cell carcinoma (RCC) has progressively increased, particularly for larger and more complex masses
Externí odkaz:
https://doaj.org/article/724dc498eea342869621a2c015094d6d
Autor:
Muhieddine Labban, Mazen Mansour, Nicolas Abdallah, Rola Jaafar, Wassim Wazzan, Muhammad Bulbul, Albert El-Hajj
Publikováno v:
Investigative and Clinical Urology, Vol 62, Iss 2, Pp 210-216 (2021)
Purpose: Aquablation is a new technology that relies on real-time ultrasound guidance to ablate prostatic tissues using high velocity pressurized water. We hereby present our data and experience in this technique by exploring the perioperative surgic
Externí odkaz:
https://doaj.org/article/4f1a93c25121459d8bcc8ecc99a84fa4
Autor:
Mark Khauli, Nassib Abou Heidar, Jad A Degheili, Nizar Hakam, Mouhamad Al-Moussawy, Mohammed Shahait, Jose El-Asmar, Gerges Bustros, Ali Merhe, Rami Nasr, Muhammad Bulbul, Wassim Wazzan, Albert El-Hajj, Ali Shamseddine, Hala Kfoury, Deborah Mukherji, Raja Khauli
Publikováno v:
Urology Annals, Vol 13, Iss 2, Pp 130-133 (2021)
Introduction: Renal cell carcinoma (RCC) has various histopathological tumor subtypes which have a significant implication on the oncological outcome of these patients. We aimed to evaluate the distribution of RCC subtypes presenting at a tertiary ca
Externí odkaz:
https://doaj.org/article/7459dc343e6346ec9707f47780a936e6
Autor:
Marilyne Daher, Talar Telvizian, Christelle Dagher, Zahi Abdul-Sater, Sarah Abdel Massih, Alissar EL Chediak, Maya Charafeddine, Mohammed Shahait, Raafat Alameddine, Sally Temraz, Fady Geara, Bassem Youssef, Albert El Hajj, Rami Nasr, Wassim Wazzan, Muhammad Bulbul, Raja Khauli, Ali Shamseddine, Deborah Mukherji
Publikováno v:
Urology Annals, Vol 13, Iss 4, Pp 418-423 (2021)
Objectives: Prostate cancer incidence is increasing in the Middle East (ME); however, the data of stage at the diagnosis and treatment outcomes are lacking. In developed countries, the incidence of de novo metastatic prostate cancer ranges between 4%
Externí odkaz:
https://doaj.org/article/05f235518cb64737bc5964a3e78721eb
Autor:
Mohammad Hout, Ali Merhe, Nassib Abou Heidar, Jose M. El-Asmar, Wassim Wazzan, Bassel Bachir, Rola Jaafar, Albert El-Hajj, Muhammad Bulbul
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 93, Iss 4 (2021)
Background: The aim of our study was to evaluate the outcome of active surveillance (AS) for prostate cancer for a cohort of patients at our institution. Methods: A total of 43 patients with low risk prostate cancer were enrolled in an active surveil
Externí odkaz:
https://doaj.org/article/956c5d127cf34be7b536bbc25f384106
Autor:
Ibrahim El Halabi, Ziad El Husseini, Yolla Haibe, Maya Charafeddine, Deborah Mukherji, Sally Temraz, Muhammad Bulbul, Raja Khauli, Rami Nasr, Wassim Wazzan, Albert El Hajj, Fady Geara, Ali Shamseddine
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100222- (2020)
Background: Radical cystectomy (RC) remains the standard of care for muscle-invasive bladder cancer (MIBC). Because of the higher overall risks associated with RC, particularly in the elderly patients with multiple comorbidities, other less invasive
Externí odkaz:
https://doaj.org/article/4ed66386a1e94e80b950b34ed3fec12e
Autor:
Katia A. Cheaito, Hisham F. Bahmad, Ola Hadadeh, Eman Saleh, Christelle Dagher, Miza Salim Hammoud, Mohammad Shahait, Zaki Abou Mrad, Samer Nassif, Ayman Tawil, Muhammad Bulbul, Raja Khauli, Wassim Wazzan, Rami Nasr, Ali Shamseddine, Sally Temraz, Marwan E. El-Sabban, Albert El-Hajj, Deborah Mukherji, Wassim Abou-Kheir
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Prostate cancer (PCa) is the second most frequent cause of cancer-related death in men worldwide. It is a heterogeneous disease at molecular and clinical levels which makes its prognosis and treatment outcome hard to predict. The epitheli
Externí odkaz:
https://doaj.org/article/65a22da292624fbba4f947bd11dc773f
Autor:
Nassib Abou Heidar, Nizar Hakam, Jose M El-Asmar, Jad Najdi, Mark A. Khauli, Jad Degheili, Albert El-Hajj, Rami Nasr, Wassim Wazzan, Muhammad Bulbul, Deborah Mukherji, Raja Khauli
Publikováno v:
Arab journal of urology. 20(3)
The aim of this study is to evaluate the significance of the R.E.N.A.L nephrometry scoring system in predicting perioperative and oncological outcomes and determining the surgical approach of choice for kidney tumors.Patients and Methods: Our study r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d813c1835713d3e9900c734e15ee821
https://pubmed.ncbi.nlm.nih.gov/35935911
https://pubmed.ncbi.nlm.nih.gov/35935911
Publikováno v:
Urology Case Reports, Vol 2, Iss 3, Pp 89-92 (2014)
Angiomyxolipoma is considered a very rare subtype of lipoma, with the latter being the most common type of mesenchymal neoplasm. Only 17 cases have been described in English medical literature. Angiomyxolipomas have been described in many locations,
Externí odkaz:
https://doaj.org/article/43bdc3aa562a4ed6a1184c4581a27ec8
Autor:
Wassim Wazzan, Alissar El Chediak, Sally Temraz, Muhammad Bulbul, Marilyne Daher, Raja B. Khauli, Sarah Abdel Massih, Rami Nasr, Ali Shamseddine, Maya Charafeddine, Christelle Dagher, Talar Telvizian, Raafat Alameddine, Deborah Mukherji, Fady Geara, Bassem Youssef, Albert El Hajj, Mohammed Shahait, Zahi Abdul-Sater
Publikováno v:
Urology Annals
Urology Annals, Vol 13, Iss 4, Pp 418-423 (2021)
Urology Annals, Vol 13, Iss 4, Pp 418-423 (2021)
Objectives: Prostate cancer incidence is increasing in the Middle East (ME); however, the data of stage at the diagnosis and treatment outcomes are lacking. In developed countries, the incidence of de novo metastatic prostate cancer ranges between 4%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e141ea2f2a5c899ce7f1f47ce8beab9
http://europepmc.org/articles/PMC8525480
http://europepmc.org/articles/PMC8525480